| 摘要 |
<p>The present invention is directed to a pharmaceutical administration form of parathyroid hormone or parathyroid hormone derivatives having an active ingredient release period of from two to six hours, the use of parathyroid hormone for the preparation of such pharmaceutical administration forms, and to a method for treating osteoporosis in the human body.</p> |
